| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.043 | 0.3 |